Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Japan Trust PLC Regulatory News (BGFD)

Share Price Information for Baillie Gifford Japan Trust PLC (BGFD)

Share Price is delayed by 15 minutes
Get Live Data
953.00    -14.00 (-1.45%)
Bid:
949.00
Ask:
950.00
Spread: 1.00 (0.105%)
Market Cap: £645.19m
BGFD Live PriceLast checked at - London Stock Exchange

Intraday Baillie Gifford Japan Trust PLC Share Chart

Replacement - Result of AGM

11 Dec 2025 12:07

RNS Number : 2309L
Baillie Gifford Japan Trust PLC
11 December 2025
 

The following amendment has been made to the Replacement - Result of AGM announcement released on 10/12/2025 at 17:18 under RNS No 0836L.

 

The date under Resolution number 10 and 13d should read 31 August 2026.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

THE BAILLIE GIFFORD JAPAN TRUST PLC (BGFD)

Legal Entity Identifier: 54930037AGTKN765Y741

Results of Annual General Meeting 

At the Annual General Meeting ('AGM') held on 10 December 2025 shareholders approved the following Resolutions:

Ordinary Resolutions

1. To receive and adopt the Financial Statements of the Company for the year ended 31 August 2025 with the Reports of the Directors and of the Independent Auditor thereon.

2. To approve the Directors' Annual Report on Remuneration for the year ended 31 August 2025.

3. To declare a final dividend of 10p per ordinary share.

4. To re-elect Sam Davis as a Director.

5. To re-elect Sharon Brown as a Director.

6. To re-elect Joanna Pitman as a Director.

7. To re-elect Patricia Lewis as a Director.

8. To reappoint Ernst & Young LLP as Independent Auditor of the Company to hold office until the conclusion of the next Annual General Meeting at which the Financial Statements are laid before the Company.

9. To authorise the Directors to determine the remuneration of the Independent Auditor of the Company.

10. That pursuant to article 165 of the Articles of Association of the Company, this meeting hereby approves the continuance of the Company until the Annual General Meeting of the Company held in respect of the year to 31 August 2026.

11. That, in substitution for any existing authority but without prejudice to the exercise of any such authority prior to the date hereof, the Directors of the Company be and they are hereby generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the 'Act') to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company ('Securities') provided that such authority shall be limited to the allotment of shares and the grant of rights in respect of shares with an aggregate nominal value of up to £384,607.20 such authority to expire at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution or on the expiry of 15 months from the passing of this Resolution, whichever is the earlier, unless previously revoked, varied or extended by the Company in a general meeting, save that the Company may at any time prior to the expiry of this authority make an offer or enter into an agreement which would or might require Securities to be allotted or granted after the expiry of such authority and the Directors shall be entitled to allot or grant Securities in pursuance of such an offer or agreement as if such authority had not expired.

 

 

Special Resolutions

12. That, subject to the passing of Resolution 11 above, and in substitution for any existing power but without prejudice to the exercise of any such power prior to the date hereof, the Directors of the Company be and they are hereby generally empowered, pursuant to sections 570 and 573 of the Companies Act 2006 (the 'Act') to allot equity securities (within the meaning of section 560(1) of the Act) for cash pursuant to the authority given by Resolution 11 above, and to sell treasury shares for cash, as if section 561(1) of the Act did not apply to any such allotment or sale, provided that this power:

a) expires at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution or on the expiry of 15 months from the passing of this Resolution, whichever is the earlier, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted or treasury shares to be sold after such expiry and the Directors may allot equity securities or sell treasury shares in pursuance of any such offer or agreement as if the power conferred hereby had not expired; and

b) shall be limited to the allotment of equity securities or the sale of treasury shares up to an aggregate nominal value of £384,607.20, being approximately 10% of the nominal value of the issued share capital of the Company as at 16 October 2025.

13. That, in substitution for any existing authority, but without prejudice to the exercise of any such authority prior to the date hereof, the Company be and is hereby generally and unconditionally authorised, pursuant to and in accordance with section 701 of the Companies Act 2006 (the 'Act'), to make market purchases (within the meaning of section 693(4) of the Act) of fully paid ordinary shares of 5 pence each in the capital of the Company ('ordinary shares'), (either for retention as treasury shares for future reissue, resale, transfer or for cancellation) provided that:

a) the maximum aggregate number of ordinary shares hereby authorised to be purchased is 11,530,523.86, or, if less, the number representing approximately 14.99% of the issued ordinary share capital of the Company as at the date of the passing of this Resolution;

b) the minimum price (excluding expenses) which may be paid for each share is 5 pence;

c) the maximum price (excluding expenses) which may be paid for each ordinary share shall be not more than the higher of:

i) 5 per cent above the average closing price on the London Stock Exchange of an ordinary share over the five business days immediately preceding the date of purchase; and

ii) The amount equal to the higher of the price of the last independent trade of an ordinary share and the highest current independent bid for an ordinary share on the trading venue where the purchase is carried out; and

d) unless previously varied, revoked or renewed by the Company in a general meeting, the authority hereby conferred shall expire at the conclusion of the Annual General Meeting of the Company to be held in respect of the year ending 31 August 2026, save that the Company may, prior to such expiry, enter into a contract to purchase ordinary shares under such authority which will or might be completed or executed wholly or partly after the expiration of such authority and may make a purchase of ordinary shares pursuant to any such contract.

Resolutions 1 to 13 were passed on a poll. A breakdown of the votes registered is shown below:

Resolution

Votes for (including votes at the discretion of the Chairman)

%

Votes Against

%

Votes Withheld

Ordinary Resolutions

1

48,875,808

 99.95

25,646

0.05

 6,277

2

48,758,782

 99.81

92,793

0.19

 56,156

3

48,862,175

 99.97

13,615

0.03

 31,941

4

48,803,279

 99.89

54,282

0.11

 50,170

5

48,211,593

 98.66

652,789

1.34

 43,349

6

48,824,792

 99.90

51,245

0.1

 31,694

7

48,820,837

 99.89

52,664

0.11

 34,230

8

48,856,021

 99.96

19,152

0.04

 32,558

9

48,821,509

 99.88

58,015

0.12

 28,207

10

43,416,099

 88.82

5,465,231

11.18

 26,401

11

48,799,733

 99.84

78,986

0.16

 29,012

Special Resolutions

12

48,800,560

 99.83

81,613

0.17

 25,558

13

47,891,759

 97.96

997,925

2.04

 18,047

 

 

 

Baillie Gifford & Co Limited

Company Secretaries

10 December 2025 

 

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGGZMMZZMGGKZM
Date   Source Headline
10th Jun 20264:48 pmRNSTransaction in Own Shares
10th Jun 202612:27 pmRNSNet Asset Value(s)
9th Jun 20264:51 pmRNSTransaction in Own Shares
9th Jun 202611:44 amRNSNet Asset Value(s)
8th Jun 202611:33 amRNSNet Asset Value(s)
5th Jun 20264:51 pmRNSTransaction in Own Shares
5th Jun 202612:07 pmRNSNet Asset Value(s)
4th Jun 20264:55 pmRNSTransaction in Own Shares
4th Jun 202611:45 amRNSNet Asset Value(s)
3rd Jun 20264:51 pmRNSTransaction in Own Shares
3rd Jun 202612:18 pmRNSNet Asset Value(s)
2nd Jun 202611:07 amRNSNet Asset Value(s)
1st Jun 202612:33 pmRNSNet Asset Value(s)
1st Jun 20269:30 amRNSTotal Voting Rights
29th May 202611:47 amRNSNet Asset Value(s)
28th May 202612:12 pmRNSNet Asset Value(s)
27th May 202611:51 amRNSNet Asset Value(s)
26th May 20264:57 pmRNSTransaction in Own Shares
26th May 202611:29 amRNSNet Asset Value(s)
26th May 20269:53 amRNSNet Asset Value(s)
22nd May 202612:05 pmRNSNet Asset Value(s)
21st May 20265:09 pmRNSTransaction in Own Shares
21st May 202611:59 amRNSNet Asset Value(s)
20th May 202611:21 amRNSNet Asset Value(s)
20th May 20267:00 amRNSCircular & Notice of GM to renew Buyback Authority
19th May 20264:56 pmRNSTransaction in Own Shares
19th May 202611:54 amRNSNet Asset Value(s)
18th May 20264:59 pmRNSTransaction in Own Shares
18th May 202611:39 amRNSNet Asset Value(s)
15th May 20264:55 pmRNSTransaction in Own Shares
15th May 202611:21 amRNSNet Asset Value(s)
14th May 20264:53 pmRNSTransaction in Own Shares
14th May 202612:09 pmRNSNet Asset Value(s)
14th May 20269:27 amRNSHolding(s) in Company
13th May 20264:58 pmRNSTransaction in Own Shares
13th May 202611:27 amRNSNet Asset Value(s)
12th May 20264:54 pmRNSTransaction in Own Shares
12th May 202612:28 pmRNSNet Asset Value(s)
11th May 202611:51 amRNSNet Asset Value(s)
8th May 202611:40 amRNSNet Asset Value(s)
7th May 20264:55 pmRNSTransaction in Own Shares
7th May 202611:57 amRNSNet Asset Value(s)
6th May 202611:50 amRNSNet Asset Value(s)
5th May 202611:44 amRNSNet Asset Value(s)
5th May 20268:33 amRNSNet Asset Value(s)
1st May 20262:05 pmRNSNet Asset Value(s)
1st May 20269:51 amRNSTotal Voting Rights
30th Apr 20265:05 pmRNSTransaction in Own Shares
30th Apr 202611:32 amRNSNet Asset Value(s)
29th Apr 20264:58 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.